日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Landscape of the Peripheral Immune Response Induced by Intraoperative Radiotherapy Combined with Surgery in Early Breast Cancer Patients

早期乳腺癌患者术中放疗联合手术诱导的外周免疫反应概况

期刊:Advanced Science
影响因子:14.1
doi:10.1002/advs.202308174
Dai, Danian; Li, Xuerui; Zhuang, Hongkai; Ling, Yun; Chen, Lezi; Long, Cheng; Zhang, Jinhui; Wang, Yunjie; Li, Yuehua; Tang, Hailin; Chen, Bo
肿瘤
肿瘤免疫
乳腺癌
免疫/内分泌
发表日期：2025
文献求助 收藏

TP63 as a modulator of ferroptosis in TP53 mutations glioblastoma.

TP63 作为 TP53 突变胶质母细胞瘤中铁死亡的调节因子

期刊:Cell Death & Disease
影响因子:9.6
doi:10.1038/s41419-025-07938-w
Cai Haiping, Yang Jiahao, Luo Feifei, Gan Wu, Li Yanwen, Zhang Liang, Ke Xueying, Wahafu Alafate, Dai Danian, Wang Peng, Zhou Dong
细胞生物学
P53
铁死亡
发表日期：2025
文献求助 收藏

CircPLK1 upregulates ETS1 to confer anthracycline resistance in triple-negative breast cancer.

CircPLK1 上调 ETS1，使三阴性乳腺癌产生蒽环类药物耐药性

期刊:Journal of Translational Internal Medicine
影响因子:7.4
doi:10.1515/jtim-2025-0029
Dai Danian, Zhang Jinhui, Mo Yunxian, Song Cailu, Liu Lingrui, Chen Zhe-Sheng, Tang Hailin, Chen Bo
肿瘤
乳腺癌
发表日期：2025
文献求助 收藏

Identification of N7-methylguanosine-related miRNAs as potential biomarkers for prognosis and drug response in breast cancer

鉴定N7-甲基鸟苷相关miRNA作为乳腺癌预后和药物反应的潜在生物标志物

期刊:Heliyon
影响因子:3.6
doi:10.1016/j.heliyon.2024.e29326
Dai, Danian; Zhuang, Hongkai; Shu, Mao; Chen, Lezi; Long, Chen; Wu, Hongmei; Chen, Bo
miRNA
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏

Genetic and clinical landscape of ER + /PR- breast cancer in China

中国ER+/PR-乳腺癌的遗传和临床特征

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-023-11643-2
Dai, Danian; Wu, Hongmei; Zhuang, Hongkai; Chen, Rong; Long, Cheng; Chen, Bo
肿瘤
肿瘤免疫
乳腺癌
发表日期：2023
文献求助 收藏

Nomograms to Predict the Density of Tumor-Infiltrating Lymphocytes in Patients With High-Grade Serous Ovarian Cancer

用于预测高级别浆液性卵巢癌患者肿瘤浸润淋巴细胞密度的列线图

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2021.590414
Dai, Danian; Liu, Lili; Huang, He; Chen, Shangqiu; Chen, Bo; Cao, Junya; Luo, Xiaolin; Wang, Feng; Luo, Rongzhen; Liu, Jihong
细胞生物学
肿瘤
肿瘤免疫
卵巢癌
发表日期：2021
文献求助 收藏

PARPBP is a prognostic marker and confers anthracycline resistance to breast cancer

PARPBP是一种预后标志物，并赋予乳腺癌蒽环类药物耐药性。

期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/1758835920974212
Chen, Bo; Lai, Jianguo; Dai, Danian; Chen, Rong; Liao, Ning; Gao, Guanfeng; Tang, Hailin
PARP
肿瘤
肿瘤免疫
乳腺癌
发表日期：2020
文献求助 收藏

Adverse effects of being underweight on young female breast cancer patients with lymph node metastases

体重过轻对伴有淋巴结转移的年轻女性乳腺癌患者的不良影响

期刊:Journal of Cancer
影响因子:3.2
doi:10.7150/jca.38567
Chen, Bo; Lai, Jianguo; Guo, Liping; Dai, Danian; Chen, Rong; Wei, Guangnan; Liao, Ning
肿瘤
肿瘤免疫
乳腺癌
发表日期：2020
文献求助 收藏

Minimally invasive surgery vs laparotomy for early stage cervical cancer: A propensity score-matched cohort study

早期宫颈癌微创手术与开腹手术的比较：一项倾向评分匹配队列研究

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.3527
Dai, Danian; Huang, He; Feng, Yanling; Wan, Ting; Liu, Zhimin; Tong, Chongjie; Liu, Jihong
宫颈癌
肿瘤
肿瘤免疫
发表日期：2020
文献求助 收藏

JAK1 as a prognostic marker and its correlation with immune infiltrates in breast cancer

JAK1作为乳腺癌预后标志物及其与免疫浸润的相关性

期刊:Aging-Us
影响因子:3.9
doi:10.18632/aging.102514
Chen, Bo; Lai, Jianguo; Dai, Danian; Chen, Rong; Li, Xuan; Liao, Ning
乳腺癌
JAK1
免疫/内分泌
JAK/STAT
肿瘤
肿瘤免疫
发表日期：2019
文献求助 收藏